Regeneus Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other
companies in this sector in AUSTRALIA :
Acrux Ltd
(2021
sales of 4.79 million Australian Dollars [US$3.47 million]
of which 100%
was Developing and Commercialising products ),
Adalta Ltd
(3.99 million Australian Dollars [US$2.89 million]
of which 100%
was Pharmaceutical), and
Noxopharm Ltd
(5.75 million Australian Dollars [US$4.17 million]
of which 100%
was Clinical development).
Sales Analysis.
Sales increased substantially in 2021:
Regeneus Ltd reported sales of A$7.07 million (US$5.12 million)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 324.9%
versus 2020, when the company's sales were A$1.66 million.